title: Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA.
authors.affiliation: Department of Neurology, Kanto Central Hospital, Tokyo, Japan. orimos1@pp.iij4u.or.jp
authors.forename: S
authors.initials: S
authors.lastname: Orimo
authors.forename: E
authors.initials: E
authors.lastname: Ozawa
authors.forename: T
authors.initials: T
authors.lastname: Oka
authors.forename: S
authors.initials: S
authors.lastname: Nakade
authors.forename: K
authors.initials: K
authors.lastname: Tsuchiya
authors.forename: M
authors.initials: M
authors.lastname: Yoshimoto
authors.forename: K
authors.initials: K
authors.lastname: Wakabayashi
authors.forename: H
authors.initials: H
authors.lastname: Takahashi
mesh_terms: D019797:3-Iodobenzylguanidine / Q000493:pharmacokinetics*; D000368:Aged; D000369:Aged, 80 and over; D001921:Brain / Q000473:pathology; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D008875:Middle Aged; D019578:Multiple System Atrophy / Q000473:pathology*; D009206:Myocardium / Q000473:pathology*; D010300:Parkinson Disease / Q000473:pathology*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
chemical_list: D019797:3-Iodobenzylguanidine; D014446:Tyrosine 3-Monooxygenase